502 related articles for article (PubMed ID: 21576954)
1. Biomarkers for itch and disease severity in atopic dermatitis.
Lee CH; Yu HS
Curr Probl Dermatol; 2011; 41():136-148. PubMed ID: 21576954
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.
Wong LS; Wu T; Lee CH
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698528
[TBL] [Abstract][Full Text] [Related]
3. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
Fujii M
Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
[TBL] [Abstract][Full Text] [Related]
4. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Mollanazar NK; Smith PK; Yosipovitch G
Clin Rev Allergy Immunol; 2016 Dec; 51(3):263-292. PubMed ID: 25931325
[TBL] [Abstract][Full Text] [Related]
5. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
Front Immunol; 2021; 12():696784. PubMed ID: 34276687
[TBL] [Abstract][Full Text] [Related]
6. Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.
Lou H; Lu J; Choi EB; Oh MH; Jeong M; Barmettler S; Zhu Z; Zheng T
J Immunol; 2017 Apr; 198(7):2543-2555. PubMed ID: 28228560
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 25, thymic stromal lymphopoietin and house dust mites in pathogenesis of atopic dermatitis.
Jaworek AK; Szafraniec K; Zuber Z; Wojas-Pelc A; Jaworek J
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32776912
[TBL] [Abstract][Full Text] [Related]
8. What causes itch in atopic dermatitis?
Yosipovitch G; Papoiu AD
Curr Allergy Asthma Rep; 2008 Jul; 8(4):306-11. PubMed ID: 18606082
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
[TBL] [Abstract][Full Text] [Related]
10. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
Melnik BC
Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
[TBL] [Abstract][Full Text] [Related]
11. Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis.
Guttman-Yassky E; Facheris P; Da Rosa JC; Rothenberg-Lausell C; Del Duca E; David E; Estrada Y; Liu Y; Bose S; Chowdhury M; Munera C; Goncalves J; Nograles K; Kim BS; Lebwohl M
J Allergy Clin Immunol; 2023 Oct; 152(4):916-926. PubMed ID: 37453614
[TBL] [Abstract][Full Text] [Related]
12. New mechanism underlying IL-31-induced atopic dermatitis.
Meng J; Moriyama M; Feld M; Buddenkotte J; Buhl T; Szöllösi A; Zhang J; Miller P; Ghetti A; Fischer M; Reeh PW; Shan C; Wang J; Steinhoff M
J Allergy Clin Immunol; 2018 May; 141(5):1677-1689.e8. PubMed ID: 29427643
[TBL] [Abstract][Full Text] [Related]
13. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
[TBL] [Abstract][Full Text] [Related]
14. Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis.
Buhl T; Ikoma A; Kempkes C; Cevikbas F; Sulk M; Buddenkotte J; Akiyama T; Crumrine D; Camerer E; Carstens E; Schön MP; Elias P; Coughlin SR; Steinhoff M
Front Immunol; 2020; 11():1740. PubMed ID: 32903402
[No Abstract] [Full Text] [Related]
15. The potential role of impaired Notch signalling in atopic dermatitis.
Melnik BC
Acta Derm Venereol; 2015 Jan; 95(1):5-11. PubMed ID: 24853951
[TBL] [Abstract][Full Text] [Related]
16. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.
Kabashima K
J Dermatol Sci; 2013 Apr; 70(1):3-11. PubMed ID: 23473856
[TBL] [Abstract][Full Text] [Related]
17. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model.
Choi YY; Kim MH; Lee H; Jo SY; Yang WM
J Dermatol Sci; 2018 Sep; 91(3):292-300. PubMed ID: 29933898
[TBL] [Abstract][Full Text] [Related]
18. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.
Yang G; Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326002
[TBL] [Abstract][Full Text] [Related]
19. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis.
Kamata Y; Kimura U; Matsuda H; Tengara S; Kamo A; Umehara Y; Iizumi K; Kawasaki H; Suga Y; Ogawa H; Tominaga M; Takamori K
J Dermatol Sci; 2016 Dec; 84(3):266-271. PubMed ID: 27686401
[TBL] [Abstract][Full Text] [Related]
20. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis.
Lee CH; Chuang HY; Shih CC; Jong SB; Chang CH; Yu HS
Br J Dermatol; 2006 Jun; 154(6):1100-7. PubMed ID: 16704640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
